DEFA14A: Danimer Scientific Updates Proxy Statement for July 9, 2024 Annual Meeting

Danimer Scientific amends its proxy statement to reflect changes in voting standards for a share increase proposal and to disclose the retention of a proxy solicitor.

Summary

• Danimer Scientific has issued a supplement to its proxy statement for the annual meeting of stockholders to be held on July 9, 2024.
• The supplement addresses changes to the voting standard for Proposal 3, which concerns an amendment to increase the authorized number of Class A common stock shares.
• The voting standard has been updated to reflect an amendment to the Delaware General Corporation Law (DGCL), requiring approval by a majority of votes cast rather than a majority of outstanding shares.
• The company has retained Morrow Sodali to act as a proxy solicitor for the Annual Meeting, with a fixed fee of $15,000 plus additional fees for telephone solicitations and expenses.
• The New York Stock Exchange (NYSE) has determined that Proposal 3 is a routine matter, allowing brokers to exercise discretionary voting authority.
• Abstentions and broker non-votes will not affect the outcome of Proposal 3, as they are not considered votes cast.
• The supplement clarifies the vote requirements for each proposal, including the impact of abstentions and broker non-votes.
• The company is revising sections of the original proxy statement related to quorum, required votes, and the vote required for the share increase proposal.

Sentiment

Score: 7

Explanation: The document is a routine update to a proxy statement, indicating standard corporate governance procedures. The sentiment is neutral to slightly positive as it ensures transparency and facilitates stockholder participation.

Positives

• The update provides clarity to stockholders regarding the voting process for Proposal 3.
• The retention of a proxy solicitor may improve stockholder participation in the Annual Meeting.
• The classification of Proposal 3 as routine by the NYSE simplifies the voting process for brokers.

Future Outlook

The document does not contain specific forward-looking statements beyond the procedural aspects of the upcoming annual meeting.

Industry Context

The amendment to the Delaware General Corporation Law reflects a broader trend in corporate governance towards streamlining the process for increasing authorized shares, potentially making it easier for companies to raise capital or pursue stock-based compensation plans.

Comparison to Industry Standards

• The change in voting standard aligns Danimer Scientific with other Delaware corporations following the DGCL Amendment.
• Retaining a proxy solicitor is a common practice among publicly traded companies to ensure sufficient stockholder participation in important votes.
• The fee paid to Morrow Sodali ($15,000 fixed fee plus expenses) appears to be within the typical range for proxy solicitation services for a company of Danimer Scientific's size and complexity.

Stakeholder Impact

• The updated voting standard for Proposal 3 may impact the likelihood of the share increase proposal being approved, affecting shareholders.
• The retention of a proxy solicitor aims to ensure that all stockholders have the opportunity to participate in the voting process.

Next Steps

• Stockholders should review the updated proxy statement and vote on the proposals.
• The company will hold its Annual Meeting of Stockholders on July 9, 2024.
• Morrow Sodali will solicit proxies on behalf of the company.

Key Dates

Keywords

proxy statement, annual meeting, Danimer Scientific, share increase, voting standard, Morrow Sodali, proxy solicitor, DGCL Amendment, broker non-votes, NYSE, common stock